Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 03-2003 | 12-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,933 | -11,652 | -2,250 | -13,170 | -13,200 |
| Depreciation Amortization | 63 | 114 | 860 | 1,880 | 1,970 |
| Accounts payable and accrued liabilities | 634 | N/A | 0 | 0 | 0 |
| Other Working Capital | 940 | -572 | 280 | 17,370 | 10,790 |
| Other Operating Activity | -532 | 2,244 | 10 | 2,800 | 5,090 |
| Operating Cash Flow | $-2,828 | $-9,866 | $-1,100 | $8,880 | $4,650 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -39 | -1,123 | -1,600 | -51,880 | -4,370 |
| Net Acquisitions | N/A | 0 | 0 | 0 | -46,150 |
| Other Investing Activity | 0 | 0 | -4,210 | 3,280 | 6,820 |
| Investing Cash Flow | $-39 | $-1,123 | $-5,810 | $-48,600 | $-43,700 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 52,187 | 18,369 | 3,000 | 25,050 | 26,110 |
| Financing Cash Flow | $52,187 | $18,369 | $3,000 | $25,050 | $26,110 |
| Beginning Cash Position | 29,080 | 21,700 | 10,270 | 24,940 | 24,940 |
| End Cash Position | 78,400 | 29,080 | 6,340 | 10,270 | 12,000 |
| Net Cash Flow | $49,320 | $7,380 | $-3,920 | $-14,670 | $-12,930 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,828 | -9,866 | -1,100 | 8,880 | 4,650 |
| Capital Expenditure | -39 | N/A | 0 | 0 | 0 |
| Free Cash Flow | -2,867 | -9,866 | -1,100 | 8,880 | 4,650 |